CCL2 and inflammatory bowel disease: Concerning abundant miRNAs in donkey, miR-320a through its targets modulates the NF-κB signaling in IBD, while miR-23a and miR-145 inhibit TLR4 and IL-17 signaling, decreasing IL-6, MCP-1, and metalloproteinases production [86].